When was ACRO Biosystems founded?

ACRO Biosystems was founded in 2016.

Where is ACRO Biosystems located?

ACRO Biosystems is headquartered in Newark, United States. It is registered at Newark, Delaware.

How many employees does ACRO Biosystems have?

As of Apr 30, 2026, the latest employee count at ACRO Biosystems is 183.

Is ACRO Biosystems a funded company?

ACRO Biosystems is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does ACRO Biosystems rank among its competitors?

ACRO Biosystems ranks 7th amongst 126 active competitors, of which 13 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was PrognomiQ, which secured $11.9M in Jan, 2026.

Who are the top competitors of ACRO Biosystems?

ACRO Biosystems' top competitors include PrognomiQ, Toyobo and LenioBio. Among them, PrognomiQ secured the most recent funding round in January, 2026.

ACRO Biosystems - 2026 Company Profile, Funding & Competitors

Company Details

Provider of innovative tools and solutions for biopharmaceutical research and development. The company offers a wide range of products and services, including recombinant proteins, antibodies, cell lines, cell culture reagents, kits & assay reagents, and viral antigens & antibodies. These products support various stages of drug discovery and development, spanning cell therapy, gene therapy, therapeutic antibodies, antibody-drug conjugates, and vaccines. The company provides custom development services, analytical testing, and GMP-grade products. It caters to preclinical and clinical research needs, offering solutions for pharmacokinetic studies, biomarker research, toxicity studies, and immunogenicity studies. The company supports researchers and manufacturers with tools for cell therapy, gene editing, and quality control, focusing on innovation in areas like organoid research, CAR-T cell therapy, and vaccine development. The website offers login, cart, and language selection options.

Website: www.acrobiosystems.com/
Social
Registered Address: Newark, Delaware

Key Metrics

Founded Year

2016

Location

Newark, United States

Stage

Funding Raised

Investors

Puhua Capital & 1 more

Ranked

7^th among 126 active competitors

Employee Count

183 as on Apr 30, 2026

Similar Companies

PrognomiQ & 153 more

View ACRO Biosystems' full profile

ACRO Biosystems is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
ACROBIOSYSTEMS INC CIN: 300789687 , United States, Active		-	50 (As on Dec 31, 2024)	-

ACRO Biosystems is a funded company. ACRO Biosystems has 2 institutional investors.

View details of ACRO Biosystems's funding rounds and investors

ACRO Biosystems' employee count trend

ACRO Biosystems has 183 employees as of Apr 26. Here is ACRO Biosystems's employee count trend over the years:

Employee count trend for ACRO Biosystems

Uncover ACRO Biosystems' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of ACRO Biosystems include PrognomiQ, Toyobo and LenioBio. Here is the list of Top 10 competitors of ACRO Biosystems, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	PrognomiQ 2020, San Mateo (United States), Series D	Developer of tests for the detection and treatment of cancer and other diseases	$135M	Bruker, Seer & 9 others	63/100
2nd	Toyobo 1882, New York City (United States), Public	Provider of functional polymers, industrial materials, and healthcare products	-	-	57/100
3rd	LenioBio 2016, Dusseldorf (Germany), Series A	Provider of kit for cell-free protein expression for accelerating drug delivery	$13M	Bridford Group, European Innovation Council ... & 7 others	56/100
4th	PreOmics 2014, Munich (Germany), Series B	Provider of reagents and instruments for proteomics research	$19.1M	Think.Health, Bruker & 23 others	55/100
5th	Navinci Diagnostics 2004, Uppsala (Sweden), Series A	Developer of products for the detection and quantification of proteins	$8.49M	Segulah Medical Acceleration, Landegren Gene Technology ... & 3 others	54/100
6th	List Biological Laboratories 1978, Campbell (United States), Acquired	Specializes in the production of research reagents	$48.4M	Korea Investment Value Asset Management, Korea Investment Holdings ... & 1 others	49/100
7th	ACRO Biosystems 2016, Newark (United States), Funding Raised	Provider of innovative tools and solutions for biopharmaceutical research and development	-	Puhua Capital, Share Capital	47/100
8th	Expedeon 2003, Swavesey (United Kingdom), Acqui-Hired	Reagents and kits for protein-based research	$390K	Dievini, Santander Bank & 2 others	42/100
9th	Cellvoyant 2021, United Kingdom, Seed	Developer of AI-driven cell analytics platform and process optimisation services	$11.9M	Octopus Ventures, Air Street Capital & 7 others	40/100
10th	Rekom Biotech 2011, Granada (Spain), Funding Raised	Recombinant antigen for IVD industry	-	CDTI	40/100